MAPT and Alzheimer disease: Delivery of TRIM11 to the CNS via the adeno-associated virus AAV9 vector protected 3×Tg-AD mice, a mouse model resembling human AD, by reducing levels of hyperphosphorylated tau and limiting cognitive and behavioral deficits [56].